
Secukinumab Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 150 mg/mL
Reference Brands: Cosentyx
Category: Osteoporosis
Secukinumab is available in Injection and strengths such as 150 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Secukinumab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Secukinumab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Secukinumab (Cosentyx®) is a leading IL-17A monoclonal antibody approved for the treatment of moderate-to-severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. It is available as a 150 mg/mL prefilled syringe or autoinjector, designed for convenient subcutaneous administration. Trusted globally under the Cosentyx brand by Novartis, it is used in dermatology and rheumatology settings across the US and EU. Manufactured under GMP/ICH-compliant standards, Secukinumab is ideal for B2B pharmaceutical buyers, including hospitals, clinics, and specialty pharmacies. Contact us for bulk export, regulatory support, and competitive pricing.
Frequently Asked Questions
Related Products
Denosumab
Strength: 60 mg/mL, 120 mg/1.7 mL
Form: Injection
Reference Brands: Prolia, Xgeva
View DetailsZoledronic Acid
Strength: 5 mg/100 mL, 4 mg/5 mL (reconstituted)
Form: Injection
Reference Brands: Reclast, Zometa,Aclasta,
View DetailsCalcium Citrate + Alfacalcidol + Zinc Sulphate Tablet
Strength: 1000mg + 0.25mcg + 7.5mg
Form: Tablets
Reference Brands:
View DetailsQuick Response Guaranteed | Verified Suppliers